Parameter | IPBC | Propiconazole | Product |
---|---|---|---|
EC50 from regulatory source | 0.067 mg l−1 | 4.3 mg l−1 | n.a. |
EC50 observed in the present study | n.a. | n.a. | 96.1 mg product/l |
Maximum allowed concentration in the product according to label | 3960.4 mg l−1 | 7920.8 mg l−1 | n.a. |
Nominal proportion (P i ) in the product, based on maximum allowed concentration | 0.3333 | 0.6667 | n.a. |
EC50 observed in the present study, based on nominal proportions | n.a. | n.a. | 1.142 mg sum of IPBC and propiconazole/l |
EC50 predicted by CA, based on nominal proportions | n.a. | n.a. | 0.195 mg sum of IPBC and propiconazole/l |
MDR, nominal | n.a. | n.a. | 0.17 |
Recovery (initial measured in percent of nominal concentration), averaged over three concentration levels | 91.4% | 84.6% | n.a. |
Corrected concentration in product, based on initial measured concentrations in test | 3620 mg l−1 | 6701 mg l−1 | n.a. |
Corrected P i in the product, based on corrected concentrations in the product | 0.3507 | 0.6493 | n.a. |
EC50 observed in the present study, based on corrected P i | n.a. | n.a. | 0.992 mg sum of IPBC and propiconazole l−1 |
EC50 predicted by CA, based on corrected P i | n.a. | n.a. | 0.186 mg sum of IPBC and propiconazole l−1 |
MDR, corrected for initial measured concentrations | n.a. | n.a. | 0.19 |